ISEC Healthcare : Results of the Annual General Meeting held on 22 April 2022

ISEC HEALTHCARE LTD.

(Company Registration No. 201400185H) (Incorporated in Singapore on 2 January 2014)

RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 22 APRIL 2022

Unless otherwise defined, all capitalised terms shall bear the same meanings as ascribed to them in the Company's annual report dated 7 April 2022.

The Board of Directors (the "Board") of ISEC Healthcare Ltd. (the "Company") is pleased to announce that all the resolutions as set out in the Company's Notice of Annual General Meeting dated 7 April 2022 were duly passed at the Annual General Meeting ("AGM") of the Company held via webcast and audio feed on 22 April 2022.

The information as required under Rule 704(15) of the Listing Manual Section B: Rules of Catalist of Singapore Exchange Securities Trading Limited ("Catalist Rules") is set out below:

(a) Breakdown of all valid votes cast at the AGM

The results of the poll on each of the resolutions put to vote at the AGM are set out below:

(b) Details of parties who are required to abstain from voting on any resolution(s), including the number of shares held and the individual resolution(s) on which they are required to abstain from voting

Ordinary Resolution 4 - Re-election of Ms Zhang Yongmei as a Director of the Company

To demonstrate good corporate governance, DBS Nominees Pte Ltd that is holding 305,917,344 ordinary shares in the Company for Aier Eye International (Singapore) Pte. Ltd., had voluntarily abstained from voting on Ordinary Resolution 4 in respect of the re-election of Ms Zhang Yongmei as a Director of the Company.

Ordinary Resolution 9 - Authority to issue shares under the ISEC Healthcare Share Option Scheme Ordinary Resolution 10 - Authority to allot and issue shares under the ISEC Healthcare Performance Share Plan

To similarly demonstrate good corporate governance, all shareholders who are voting and are entitled to participate in the ISEC Healthcare Share Option Scheme and ISEC Healthcare Performance Share Plan, including the Chief Executive Officer, Dr Wong Jun Shyan, as well as employees of the Group (including Dr Lee Yeng Fen), holding an aggregate of 113,033,823 ordinary shares in the Company, had abstained from voting on Ordinary Resolutions 9 and 10 in respect of the authority to issue Shares under the ISEC Healthcare Share Option Scheme and the authority to issue Shares under the ISEC Healthcare Performance Share Plan respectively.

(c) Name of firm appointed as scrutineer

Agile 8 Advisory Pte. Ltd. was appointed as the scrutineer for the conduct of poll at the AGM.

(d) Re-election of Directors to the Audit Committee

Mr Lim Wee Hann who was re-elected as a Director of the Company at the AGM, remains as Chairman of both the Remuneration and Nominating Committees and a member of the Audit Committee. Mr Lim is considered by the Board to be independent for the purposes of Rule 704(7) of the Catalist Rules.

Ms Zhang Yongmei who was re-elected as a Director of the Company at the AGM, remains as a member of the Audit, Remuneration and Nominating Committees. Ms Zhang is considered by the Board to be non-independent.

Mr Chong Weng Hoe who was re-elected as a Director of the Company at the AGM, remains as Chairman of the Board and Audit Committee and a member of the Remuneration and Nominating Committees. Mr Chong is considered by the Board to be independent for the purposes of Rule 704(7) of the Catalist Rules.

By Order of the Board

Dr. Lee Hung Ming Executive Vice Chairman 22 April 2022

This announcement has been reviewed by the Company's sponsor, PrimePartners Corporate Finance Pte. Ltd. (the "Sponsor"). It has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "Exchange") and the Exchange assumes no responsibility for the contents of this document, including the correctness of any of the statements or opinions made or reports contained in this document.

The contact person for the Sponsor is Ms Gillian Goh, 16 Collyer Quay, #10-00 Income at Raffles, Singapore 049318,sponsorship@ppcf.com.sg.